Gene Editing by Cystolic Intracellular Delivery
Exclusively Licensed
Invention type: Technology
/
Case number: #17635J
Gene editing can be performed by introducing gene-editing components into a cell by mechanical cell disruption. Related apparatus, systems, techniques, and articles are also described.
Researchers
Robert Langer
/
Alexandra Eyerman
/
Prashant Mali
/
Marc Lajoie
/
Armon Sharei
/
Klavs F. Jensen
Departments: Office of the Institute Professors, Department of Chemical Engineering
Technology Areas: Biotechnology: Biomedical Devices & Systems, DNA & RNA Editing / Drug Discovery and Research Tools: Cell Interrogation
Impact Areas: Healthy Living
-
gene editing through microfluidic delivery
United States of America | Granted | 12,130,281 -
gene editing by cystolic intracellular delivery
Canada | Published application -
gene editing by cystolic intracellular delivery
Australia | Granted | 2,016,206,870 -
gene editing by cystolic intracellular delivery
European Patent Convention | Published application -
gene editing through microfluidic delivery
Japan | Granted | 7,278,027 -
gene editing through microfluidic delivery
United States of America | Granted | 11,125,739 -
gene editing by cystolic intracellular delivery
China | Published application -
gene editing through microfluidic delivery
Japan | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.